Dikkopf-1 (DKK-1) is a key regulatory protein involved in bone metabolism. It inhibits signals that promote bone formation, making it a significant indicator in various bone and joint disorders.
To find out more about the Novel Biomarkers – DDK-1, enquire now.
Dikkopf-1 (DKK-1) is a key regulatory protein involved in bone metabolism. It inhibits signals that promote bone formation, making it a significant indicator in various bone and joint disorders. Elevated or decreased levels of DKK-1 may reflect changes in bone remodelling, positioning it as a valuable biomarker across a wide range of diseases—including rheumatoid arthritis, osteoporosis, osteoarthritis, and certain cancers.
DKK-1 levels can be integrated into diagnostic panels to enhance disease detection and stratify risk:
Randox biochip technology enables precise measurement of sPD-1, providing valuable insights into immune regulation and disease progression.


The Evidence MultiSTAT is an easy to use, small footprint analyser facilitating on-site simultaneous detection of multiple biomarkers.
Using chemiluminescence as a measurement principle, the Evidence MultiSTAT consistently delivers accurate results.
With minimal sample preparation required, this versatile benchtop analyser can achieve accurate, quantitative results in minutes.

The Evidence MultiSTAT cartridge contains the reagents required for the chemiluminescent reaction to take place incorporated into its wells.
The process from sample entry to results can be completed in 2 simple steps, with minimal risk of human error.
No other components are required.